I. Gwaje-gwajen Kimiya na Junk a matsayin Tushen Lasisi na FDA na allurar Hepatitis B a Amurka
Kwamitin Ba da Shawarwari kan Ayyukan rigakafi (ACIP) zai tattauna batun rigakafin cutar hanta na B a taron su na Disamba 4 da 5. A cikin wannan labarin zan fitar da shari'ar cire allurar rigakafin cutar hanta B daga jadawalin yara na CDC gaba ɗaya.
Kamar yadda Informed Consent Action Network ke da shi nuna, allurar rigakafin cutar hanta na B Recombivax da Engerix - allurar da aka yi wa yawancin yaran Amurka a lokacin haihuwa, wata daya, da watanni shida - bai kamata FDA ta ba da lasisi ba a farkon wuri.
Gwajin asibiti na Recombivax da Engerix:
- bai haɗa da ƙungiyar kulawar saline mai kyau ba;
- sun yi ƙanƙanta don gano abubuwan da ba a saba gani ba; kuma
- sun kasance gajere sosai don gano yawancin lahani (gwajin Recombivax sun kula da aminci na kwanaki biyar kacal, gwajin Engerix ya sa ido akan abubuwan da suka faru na rashin hankali na kwanaki hudu kawai).
II. Alurar Hepatitis B Suna Haɗe da Autism
Bayanai na ainihi na duniya waɗanda ke samuwa akan amincin rigakafin cutar hanta B suna da ban tsoro. Lokacin da adadin Autism a Amurka ya fashe a cikin 1990s, CDC ta duba yuwuwar rawar rigakafin. Sun sanya ɗaya daga cikin manyan masana kimiyyar su, Thomas Verstraeten, a Sabis na Leken Asiri, don yin bincike. A lokacin, allurar rigakafin hanta na B suna da mercury (thimerosal) a cikinsu. Dokta Verstraeten ya gano cewa yara a cikin mafi girman rukuni suna da 11.35x ya karu da haɗari na autism.
Source: SafeMinds.
Bayan haka, saboda CDC tana aiki don masana'antar harhada magunguna, Dr. Verstraeten ya yi ƙarin zagaye huɗu na sarrafa bayanai, waɗanda ba su da garantin kimiyya, don ƙoƙarin sa siginar ta tafi. Muna da imel ɗin Dr. Verstraeten da bincike daban-daban guda biyar saboda SafeMinds sun yi buƙatar FOIA don samun duk sadarwar Dr. Verstraeten game da binciken (duba SafeMinds Powerpoint gabatarwa nan). An yi amfani da bayanan da aka lalata a cikin takarda da aka buga na ƙarshe kuma an rufe ainihin binciken.
CDC tana da wannan bayanin a cikin 1999 kuma ta yi ƙarya game da shi tsawon shekaru 26 (wanda na ambata a cikin kwanan nan. Shaidar Majalisar Dattawa). A cikin 2001, Dr. Verstraeten ya shirya gabatar da bincikensa ga Cibiyar Nazarin Magunguna amma ya bar ranar da safe na gabatarwa don tafiya aiki ga masana'antar rigakafin GlaxoSmithKline a Belgium (duba. Tabbacin Cutar).
A ƙarshe an fitar da Mercury daga allurar hanta na B; duk da haka aluminum adjuvants sun kasance. CDC/ACIP daga baya sun ƙara ƙarin almummuka da yawa masu ɗauke da alluran rigakafi zuwa jadawalin yara. Abin da muke gani a cikin bayanan yaduwar autism bayan cire mercury, tare da karuwa a cikin jimlar aluminum a cikin jadawali, shi ne cewa ƙimar autism ta ci gaba da karuwa (saboda karuwar aluminum) amma yawancin lokuta masu tsanani na autism a matsayin kashi na jimlar sun ƙi kaɗan (saboda kawar da thimerosal wanda ya fi guba fiye da aluminum).
III. Alurar Hepatitis B Sun Kashe Adadin Yara Masu Ban Mamaki A Amurka
Na tambayi jarumi mamas a Buɗe VAERS (waɗanda ke yin aikin da ya kamata CDC ta yi) don ƙididdige adadin adadin waɗanda suka mutu daga allurar hanta B daga 1990 zuwa yanzu. Sakamakon da ya dawo ya nuna cewa allurar rigakafin cutar hanta B laifi ne ga bil'adama.
Hepatitis B wani bangare ne a cikin alluran hade da yawa da suka hada da Twinrix, Pediarix, da Vaxelis. Lokacin da mutum ya dubi rahotannin VAERS a Amurka na duk allurar rigakafin da ke ɗauke da sashin cutar hanta B akwai mace-mace 1,320 a cikin yara masu shekaru 5 da ƙanana da 82,980 jimlar rahotannin cutarwa a duk shekaru daban-daban.
Kawai kallon Recombivax da Engerix, rahotannin Amurka, a cikin yara masu shekaru 5 da ƙasa, akwai mutuwar 620 da jimillar raunuka 15,110. Akwai jimillar rahotanni 52,281 na rauni a cikin Amurka a duk tsawon shekaru na Recombivax da Engerix.
Ka tuna cewa rahotannin VAERS suna da mahimmanci undercount na cutarwa. Li'azaru da Klompas suna nazarin HHS a cikin 2011 an kiyasta cewa VAERS na ƙididdige ainihin illolin da adadin 100x. Ƙarin ƙwarewa na kwanan nan ta Steve Kirsch, Mathew Crawford, da Jessica Rose a 2021 Ƙididdigar VAERS Ƙarƙashin Rahoto Factor na 41x.
Irin wannan ƙididdiga ta VAERS Analysis (dole ne ba a san sunansa ba saboda Pharma ke farautar masu fallasa) 2021 yana nuna Factor ɗin Ba da Rahoto na 44.64x don mace-mace. Idan wannan Factor Ƙarƙashin Bayar da Rahoto daidai ne, to, kimanin yara 58,925 masu shekaru biyar zuwa ƙasa duk allurar rigakafin cutar hanta ta B sun kashe a cikin shekaru 35 da suka gabata a Amurka; na wannan jimillar, an kiyasta kimanin yara 27,677 masu shekaru biyar zuwa sama da Recombivax da Engerix sun kashe a Amurka a cikin wannan lokacin.
OpenVAERS kuma sun ƙididdige "kwanakin zuwa mutuwa bayan allurar rigakafi" ga duk rahoton VAERS na mutuwar da ke da alaƙa da ciwon hanta na B mai ɗauke da alluran rigakafi da na Recombivax da Engerix. A can muna da bindiga mai shan taba kamar yadda mafi yawan adadin wadanda suka mutu shine ranar alurar riga kafi ko kwana daya ko biyu bayan.
IV. Kammalawa: Dole ne a Cire Alurar Hepatitis B Gabaɗaya daga Jadawalin Yarancin CDC
Membobin ACIP suna fuskantar babban matsin lamba daga Rukunin Masana'antu na Magunguna don kawai jinkirta lokacin rigakafin cutar hanta na B zuwa ranar 30 ko zuwa 12 shekaru. Duk da haka, gaskiyar ta kasance cewa babu wani bayanan da ke tabbatar da aminci da ingancin alluran ciwon hanta na B a rana ta 1, ranar 30, ko 12 shekaru.
Idan mutum yana so ya koma "Gold Standard Science" dole ne ya gudanar da gwaje-gwajen da bazuwar makafi guda biyu, tare da placebo saline mai inert a cikin ƙungiyar kulawa, babban girman samfurin (aƙalla 60,000) don gano abubuwan da ba a saba gani ba, da kuma isasshen kulawa bayan allurar rigakafi (shekaru 10) don kama abubuwan da ba na musamman ba.
Babu "Gold Standard" maganin rigakafin cutar hanta na B aminci da ingantaccen bincike a cikin yawan yara ya wanzu a yanzu don haka dole ne a cire allurar hanta B gabaɗaya daga jadawalin yara na CDC.
An samar da allurar rigakafin cutar hepatitis B ga masu shan miyagun ƙwayoyi na IV da karuwai saboda waɗannan sune ƙungiyoyi masu haɗari. Idan za a yi amfani da allurar rigakafin cutar hanta kwata-kwata, a gwada su yadda ya kamata a mayar da su zuwa waccan manufar ta asali da kuma kasuwar da aka yi niyya. Idan masu gadin gidan yari suna son samun su ma saboda suna mu'amala da yawan jama'a masu haɗari yana da kyau. Har ila yau, amfanin alurar rigakafin cutar hanta B ya bayyana ya zarce haɗarin yara da aka haifa ga iyaye mata masu ciwon hanta (kuma mun san ainihin su waye yaran saboda duk mata masu ciki ana gwada cutar hanta na B a asibiti kafin haihuwa). Duk da haka, ra'ayin ba da allurar rigakafin cutar hanta na B ga kusan daukacin al'ummar ƙuruciyar hauka ce ta zahiri.
Anan ga cikakken labarin a cikin bayanan shafi guda ɗaya wanda OpenVAERS ya ƙirƙira. Da fatan za a raba shi tare da hanyoyin sadarwar ku saboda rayuwar dubban yara da makomar Jamhuriyar suna kan layi.
An sake bugawa daga marubucin Mayarwa
-
Toby Rogers yana da Ph.D. a cikin tattalin arzikin siyasa daga Jami'ar Sydney a Ostiraliya da kuma Jagoran Digiri na Siyasa na Jama'a daga Jami'ar California, Berkeley. Binciken nasa ya mayar da hankali kan kame ka'idoji da cin hanci da rashawa a masana'antar harhada magunguna. Dokta Rogers yana gudanar da tsarin siyasa na asali tare da ƙungiyoyin 'yanci na likita a duk faɗin ƙasar da ke aiki don dakatar da annobar cutar rashin lafiya a cikin yara. Ya yi rubutu game da tattalin arzikin siyasa na lafiyar jama'a akan Substack.
Duba dukkan posts
